Concord Medical Services
3 hedge funds and large institutions have $108K invested in Concord Medical Services in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 2 closing their positions.
0% less ownership
Funds ownership: 0.01% → 0.01% (-0%)
37% less capital invested
Capital invested by funds: $173K → $108K (-$64.9K)
40% less funds holding
Funds holding: 5 → 3 (-2)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$22.7K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$2.85K |
| 3 |
Citigroup
New York
|
-$328 |
CCM Hedge Fund Activity: Q1 2023 in Review
3 of the 6,282 institutional investors tracked by Wall St. Rank reported a position in Concord Medical Services (CCM) for Q1 2023, worth a combined $108K — down 37% from $173K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of CCM and 0 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 0 added.
The largest seller was Renaissance Technologies, cutting an estimated $22.7K.
- 3 institutional investors held Concord Medical Services (CCM) as of Q1 2023, down from 5 in Q4 2022.
- Funds reported $108K of Concord Medical Services stock for Q1 2023, down 37% quarter-over-quarter.
- 0 funds opened new Concord Medical Services positions in Q1 2023 and 2 closed out, a net change of -2 holders.
- The largest Concord Medical Services seller in Q1 2023 was Renaissance Technologies, an estimated $22.7K sold.
Based on aggregated 13F filings for Q1 2023.